6th Arab and Southern European Countries Masterclass in Clinical Oncology
30 ESCO credits
15.12.2017 - 18.12.2017
Limassol, Cyprus
MASTERCLASS
Breast cancer, Gastro-intestinal tumours, Gynaecological cancers, Lung cancer, Lymphoma, Medical / clinical oncology, Prostate cancer
Description
Chairs: M.S. Aapro, CH - N. Pavlidis, GR
Co-chairs: J. Gligorov, FR - S. Khatib, JO
Host Chair: D. Papamichael, CY
This is a 3-days clinically oriented educational programme dedicated to medical, clinical and radiation oncologists, who wish to improve their skills in oncology. The programme focuses on breast, gynaecological, prostate, colorectal, lung cancers and on lymphomas and its covered by an international faculty of top experts.
The Masterclass offers:
• plenary lectures regarding state-of-the art clinical evaluation and treatments with reference to clinical guidelines concluding in take-home messages;
• clinical case presentations will be delivered by the participants in Tumor Board discussions as well as in divided small groups with the presence of the chairmen and the faculty;
• a self-assessment test based on multiple choice questionnaire, will be provided to participants on the last day of the Masterclass.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission.
AIMS AND OBJECTIVES
This clinically oriented educational programme has been designed for medical and clinical oncologists who wish to improve their skills in the management of cancer patients.
The programme will expose participants to a full spectrum of issues in clinical oncology and to practice-orientated training. The programme focuses on breast, gynaecological, lung, urological and gastrointestinal cancers. Spotlight sessions will facilitate compact update on elderly patients, head and neck, melanoma, non-Hodgkin’s lymphoma, soft tissue sarcoma, supportive care.
LEARNING OBJECTIVES
• Improve medical and radiation oncologists’ skills
• Practicing case discussion
• Deep focus on breast, gynaecological, prostate, lung and colorectal cancer, lymphomas.
TEACHING FORMAT
The Masterclass offers plenary lectures discussing current issues and controversies as well as critically reviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and other evidence-based guidelines will be cited. Participants will deliver case presentations within tumour boards and discuss them with the chairs and the faculty.
All participants will reside at the course venue and participation is compulsory throughout the course. The Masterclass will be entirely in English and at least an intermediate level of English is necessary for admission.
THE MASTERCLASS:
• Full immersion
• Clinically-oriented
• Multidisciplinary
• An international faculty of top experts delivering lectures focusing on breast, gynaecological, lung, urological and gastrointestinal cancers
MAIN TOPICS
• Breast cancer
• Gynaecological cancer
• Lung cancer
• Urological cancer
• Gastrointestinal cancer
• Lymphomas
Held in collaboration with | Held under the auspices of the Arab Medical Association Against Cancer (AMAAC) |
|||||||
|
![]() |
General information
GENERAL INFORMATION
Organising secretariat
Daniela Mengato
European School of Oncology (ESO)
Via Turati 29 - 20121 Milan, Italy
Tel: +39 02 85464523
Fax: +39 02 85464545
Email: dmengato@eso.net
Applications
Alice Ciocchini
Ph: +39 02 85464529
Email: aciocchini@eso.net
Faculty list
FACULTY
M.S. Aapro, Breast Center, Genolier, CH
D. Arnold, CUF Hospitals Cancer Center, Lisbon, PT
H. Azim, Cairo University, Cairo Oncology Center, EG
H. Boussen, Institut Salah Azaiz (ISA), Tunis, TN
M.J. Cardoso, Champalimaud Foundation, Lisbon, PT
P. Casali, Fondazione IRCCS Istituto Nazionale Tumori, Milan, IT
A. Constantinidou, Medical School, University of Cyprus, Nicosia, CY
G. Curigliano, European Institute of Oncology, Milan, IT
R. Gaafar, National Cancer Institute, Cairo, EG
F. Geara, American University of Beirut, LB
J. Gligorov, APHP Tenon, IUC-UPMC, Sorbonne University, Paris, FR
J. Khader, King Hussein Cancer Center, Amman, JO
H. Khaled, National Cancer Institute, Cairo, EG
S. Khatib, Arab Medical Association Against Cancer (AMAAC), Amman, JO
O. Michielin, Lausanne University Hospital – CHUV, CH
N. Mottet, University Jean Monnet, Saint Etienne, FR
R. Orecchia, European Institute of Oncology, Milan, IT
D. Papamichael, Bank of Cyprus Oncology Centre, Nicosia, CY
N. Pavlidis, University Hospital of Ioannina, GR
G. Pruneri, European Institute of Oncology, Milan, IT
R. Stahel, University Hospital Zurich, CH
A. Stathis, Oncology Institute of Southern Switzerland (IOSI), Bellinzona, CH
J.B. Vermorken, Antwerp University Hospital, BE
Programme
14 December
Participants’ arrival and dinner |
15 December
8:00 |
Registration |
|
8:45 | Welcome address |
|
BREAST CANCER SESSION Chairs: J. Gligorov, FR - H. Azim, EG |
||
9:00 | What the clinician needs to know from the breast pathologist G. Pruneri, IT |
|
9:20 | Discussion |
|
9:30 | Current controversies/challenges in breast surgery M.J. Cardoso, PT |
|
9:50 | Discussion |
|
10:00 | The role of radiotherapy in early and locally advanced breast cancer R. Orecchia, IT |
|
10:20 | Discussion |
|
10:30 | Coffee break |
|
11:00 | Neoadjuvant/adjuvant chemotherapy and biological agents G. Curigliano, IT |
|
11:20 | Discussion |
|
11:30 | Neoadjuvant/ adjuvant endocrine therapy J. Gligorov, FR |
|
11:50 | Discussion |
|
12:00 | Management of HER2+ advanced breast cancer G. Curigliano, IT |
|
12:20 | Discussion |
|
12:30 | Management of triple-negative advanced breast cancer H. Azim, EG |
|
12:50 | Discussion |
|
13:00 | Management of ER+ advanced breast cancer J. Gligorov, FR |
|
13:20 | Discussion |
|
13:30 | Lunch |
|
14:30 | Breast Cancer Tumor Board (4 cases) |
|
GYNECOLOGICAL CANCER SESSION Chairs: A. Constantinidou, CY - J.B. Vermorken, BE |
||
15:30 | Systemic management of ovarian cancer J.B. Vermorken, BE |
|
15:50 | Discussion |
|
16:00 | Systemic management of locally advanced or metastatic cervical and endometrial cancer J.B. Vermorken, BE |
|
16:20 | Discussion |
|
16:30 | Coffee break |
|
17:00 | Gynecological Cancer Tumor Board (4 cases) |
|
20:00 | Dinner with faculty |
16 December
LUNG CANCER SESSION Chairs: R. Stahel, CH - F. Geara, LB |
||
8:30 | The impact of radiation therapy in lung cancer F. Geara, LB |
|
8:50 | Discussion |
|
9:00 | Neoadjuvant and adjuvant systemic treatment in NSCLC R. Gaafar, EG |
|
9:20 | Discussion |
|
9:30 | Systemic chemotherapy and targeted treatment in metastatic NSCLC R. Stahel, CH |
|
9:50 | Discussion |
|
10:00 | Immune check point inhibitors in NSCLC R. Stahel, CH |
|
10:20 | Discussion |
|
10:30 | Coffee break |
|
11:00 |
Management of small-cell lung cancer R. Gaafar, EG |
|
11:20 |
Discussion |
|
11:30 | Systemic management of advanced mesothelioma R. Stahel, CH |
|
11:50 | Discussion |
|
12:00 | Lung Cancer Tumor Board (4 cases) |
|
13:00 | Lunch |
|
SPOTLIGHT SESSION 1 |
||
14:00 | Modern management of melanoma O. Michielin, CH |
|
14:20 | Discussion |
|
14:30 | Update in the management of head and neck cancer J.B. Vermorken, BE |
|
14:50 | Discussion | |
15:00 | How do I manage cancer in elderly patients M.S. Aapro, CH |
|
15:20 | Discussion |
|
15:30 | Coffee break |
|
16:00 |
Parallel Group Sessions I (Cases discussion in three Groups) |
|
20:00 | Dinner with faculty |
17 December
UROLOGICAL CANCER SESSION Chairs: H. Khaled, EG - N. Mottet, FR |
||
8:30 | Management including active surveillance of localized prostate cancer J. Khader, JO |
|
8:55 | Discussion |
|
9:05 | Key topics in locally advanced, advanced and metastatic prostate cancer N. Mottet, FR |
|
9:45 | Discussion |
|
10:00 | Update in the management of bladder cancer H. Khaled, EG |
|
10:20 | Discussion |
|
10:30 | Coffee break |
|
11:00 | Update in the management of renal cancer N. Mottet, FR |
|
11:20 | Discussion |
|
11:30 | Management of relapsed testicular cancer H. Boussen, TN |
|
11:40 | Discussion | |
12:00 | Urological Cancer Tumor Board (4 cases) |
|
13:00 | Lunch |
|
SPOTLIGHT SESION 2 |
||
14:00 | Supportive care M.S. Aapro, CH |
|
14:20 | Discussion |
|
14:30 | Update in the management of soft tissue sarcomas A. Constantinidou, CY |
|
14:50 | Discussion |
|
15:00 | Update in the management of high grade NHL A. Stathis, CH |
|
15:20 | Discussion |
|
15:30 | Coffee break |
|
16:00 | Parallel Group Sessions II (Cases discussion in three Groups) |
|
20:00 | Dinner with faculty |
18 December
GASTROINTESTINAL CANCER SESSION Chairs: D. Papamichael, CY - D. Arnold, PT |
||
8:30 | Adjuvant / neoadjuvant systemic treatment in colorectal cancer D. Papamichael, CY |
|
8:50 | Discussion |
|
9:00 | Systemic treatment in advanced colon cancer D. Arnold, PT |
|
9:20 | Discussion |
|
9:30 | Radiation treatment in rectal cancer J. Khader, JO |
|
9:50 | Discussion |
|
10:00 | Systemic treatment in early and advanced gastric cancer D. Arnold, PT |
|
10:20 | Discussion |
|
10:30 | Coffee break |
|
11:00 | Gastrointestinal Cancer Tumor Board (4 cases) |
|
12:00 | Learning Self-Assessment Test |
|
13:15 | Closing and Departures | |